Yuxiang Huang

发表

Insights into the Human CD59 Complement Binding Interface Toward Engineering New Therapeutics*

R. Abagyan, Colin A. Smith, B. Morgan, 2005, Journal of Biological Chemistry.

Defining the CD59-C9 binding interaction.

R. Abagyan, S. Hazard, S. Tomlinson, 2006, The Journal of biological chemistry.

Defining the CD59-C9 Binding Interaction*

R. Abagyan, S. Hazard, S. Tomlinson, 2006, Journal of Biological Chemistry.

A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.

N. Van Rooijen, B. Morgan, C. Atkinson, 2012, Blood.

Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.

C. Davies, S. Tomlinson, Yuxiang Huang, 2007, Acta crystallographica. Section D, Biological crystallography.

Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD(Plymouth) and G6PD(Mahidol): Evidence for defective protein folding as the basis of disease.

P. Engel, S. Au, D. M. Au, 2008, Molecular genetics and metabolism.

Luteolin alleviates inorganic mercury-induced liver injury in quails by resisting oxidative stress and promoting mercury ion excretion

Changming Guo, Siyu Li, Zhigang Zhang, 2022, Molecular Biology Reports.

The role of mitochondrial dynamics imbalance in hexavalent chromium-induced apoptosis and autophagy in rat testis.

Siyu Li, Jiayi Li, Zhigang Zhang, 2023, Chemico-biological interactions.

App1: An Antiphagocytic Protein That Binds

Stephen Tomlinson, Del Poeta, Asfia Qureshi, 2013 .

App1: An Antiphagocytic Protein That Binds to Complement Receptors 3 and 21

M. Del Poeta, C. Luberto, S. Tomlinson, 2009, The Journal of Immunology.

A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.

M. Pangburn, J. Thurman, G. Gilkeson, 2010, Advances in experimental medicine and biology.

A Novel Targeted Inhibitor of the Alternative Pathway of Complement and Its Therapeutic Application in Ischemia/Reperfusion Injury1

C. Atkinson, S. Tomlinson, F. Qiao, 2008, The Journal of Immunology.

A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.

G. Gilkeson, S. Tomlinson, B. Rohrer, 2009, Investigative ophthalmology & visual science.

This information is current as to Complement Receptors 3 and 2 App 1 : An Antiphagocytic Protein

C. Luberto, S. Tomlinson, A. Qureshi, 2008 .

to Complement Receptors 3 and 2 App1: An Antiphagocytic Protein That Binds

C. Luberto, S. Tomlinson, A. Qureshi, 2022 .